Log in Register
Menu

Anti-Cytochrome P450 3A7 [F19P2H2]

Invented by Ayham Alnabulsi at Vertebrate Antibodies Limited

Info

Catalogue Number 151864
Applications ELISA IHC WB
Antigen/Gene or Protein Targets CYP3A7- Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (P450-HFLA)
Reactivity Human
Relevance This monoclonal antibody (MAb), when used in conjunction with the Mab specific to CYP3A5 clone F18 P3 B6, is able to differentiate between the CYP450 family 3 members: CYP3A5 and CYP3A7
Host Mouse
Immunogen Ovalbumin-conjugated synthetic peptide ESRDETVSGA (C-terminal sequence)
Subclass IgG1 kappa
Positive Control IHC: formalin-fixed, paraffin-embedded prostate cancer sections. Western blot: recombinant P450 (shown below @ 0.5 pmol per lane). Negative control: Gentest Cat. No M101b.
Strain Balb/c
Research Area Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism

References: 3 entries

Zia et al. 2015. Int J Exp Pathol. 96(2):81-6. PMID: 25670065.

Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.

Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.


Add a reference

References: 3 entries

Zia et al. 2015. Int J Exp Pathol. 96(2):81-6. PMID: 25670065.

Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.

Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.


Add a reference

References: 3 entries

Zia et al. 2015. Int J Exp Pathol. 96(2):81-6. PMID: 25670065.

Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.

Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.


Add a reference


This reagent does not have any reviews at the moment.